$8.22
-0.22 (-2.61%)
Open$8.38
Previous Close$8.44
Day High$8.70
Day Low$8.04
52W High$11.49
52W Low$1.76
Volume—
Avg Volume115.3K
Market Cap44.64M
P/E Ratio—
EPS$-1.60
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+68.2% upside
Current
$8.22
$8.22
Target
$13.83
$13.83
$9.36
$13.83 avg
$17.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 806.1K | 116.64M | 118.58M |
| Net Income | -8,435,973 | -21,434,773 | -22,545,743 |
| Profit Margin | -1,046.4% | -18.4% | -19.0% |
| EBITDA | -10,406,906 | -23,823,087 | -23,688,809 |
| Free Cash Flow | — | -12,084,786 | -12,382,292 |
| Rev Growth | — | -8.2% | -9.4% |
| Debt/Equity | — | 0.42 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |